PMC:7795856 / 4103-4211
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"118","span":{"begin":58,"end":61},"obj":"Gene"},{"id":"132","span":{"begin":17,"end":27},"obj":"Chemical"},{"id":"139","span":{"begin":83,"end":102},"obj":"Disease"}],"attributes":[{"id":"A118","pred":"tao:has_database_id","subj":"118","obj":"Gene:20539"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:D000074324"},{"id":"A139","pred":"tao:has_database_id","subj":"139","obj":"MESH:D007410"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ody, compared to ipilimumab therapy alone [16]. Moreover, Tα1 was shown to prevent intestinal toxicity in a "}